BRIEF-Cytokinetics announces orphan drug designation for CK-2127107 for treatment of spinal muscular atrophy
May 15, 2017 at 07:45 AM EDT
* Cytokinetics announces orphan drug designation for CK-2127107 for the treatment of spinal muscular atrophy